123 related articles for article (PubMed ID: 3493326)
1. Role of interferon in the augmented resistance of trehalose-6,6'-dimycolate-treated mice to influenza virus infection.
Azuma M; Suzutani T; Sazaki K; Yoshida I; Sakuma T; Yoshida T
J Gen Virol; 1987 Mar; 68 ( Pt 3)():835-43. PubMed ID: 3493326
[TBL] [Abstract][Full Text] [Related]
2. Correlation between augmented resistance to influenza virus infection and histological changes in lung of mice treated with trehalose-6,6'-dimycolate.
Azuma M; Sazaki K; Nishikawa Y; Takahashi T; Shimoda A; Suzutani T; Yoshida I; Sakuma T; Nakaya K
J Biol Response Mod; 1988 Oct; 7(5):473-82. PubMed ID: 2460592
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of augmented resistance of cyclosporin A-treated mice to influenza virus infection by trehalose-6,6'-dimycolate.
Sazaki K; Yoshida I; Azuma M
Microbiol Immunol; 1992; 36(10):1061-75. PubMed ID: 1282653
[TBL] [Abstract][Full Text] [Related]
4. Role of gamma delta TCR+ lymphocytes in the augmented resistance of trehalose 6,6'-dimycolate-treated mice to influenza virus infection.
Hoq MM; Suzutani T; Toyoda T; Horiike G; Yoshida I; Azuma M
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1597-603. PubMed ID: 9225035
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate.
Masihi KN; Brehmer W; Azuma I; Lange W; Müller S
Infect Immun; 1984 Jan; 43(1):233-7. PubMed ID: 6317568
[TBL] [Abstract][Full Text] [Related]
6. Insufficient resistance of trehalose-6,6-dimycolate-treated T-cell receptor delta gene mutant (TCR delta-/-) mice against influenza virus infection.
Hoq MM; Suzutani T; Nakaya K; Yoshida I; Ogasawara M; Takeda Y; Shibaki T; Itohara S; Yamamoto H; Azuma M
Microbiol Immunol; 1999; 43(5):491-3. PubMed ID: 10449256
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma independent formation of pulmonary granuloma in mice by injections with trehalose dimycolate (cord factor), lipoarabinomannan and phosphatidylinositol mannosides isolated from Mycobacterium tuberculosis.
Takimoto H; Maruyama H; Shimada KI; Yakabe R; Yano I; Kumazawa Y
Clin Exp Immunol; 2006 Apr; 144(1):134-41. PubMed ID: 16542375
[TBL] [Abstract][Full Text] [Related]
8. Immunobiological activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects.
Masihi KN; Lange W; Brehmer W; Ribi E
Int J Immunopharmacol; 1986; 8(3):339-45. PubMed ID: 3733302
[TBL] [Abstract][Full Text] [Related]
9. Trehalose dimycolate enhances survival of fission neutron-irradiated mice and Klebsiella pneumoniae-challenged irradiated mice.
McChesney DG; Ledney GD; Madonna GS
Radiat Res; 1990 Jan; 121(1):71-5. PubMed ID: 2405452
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of muramyl dipeptide analogs in combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium tuberculosis infections in mice.
Masihi KN; Brehmer W; Lange W; Ribi E; Schwartzman S
J Biol Response Mod; 1984 Dec; 3(6):663-71. PubMed ID: 6439830
[TBL] [Abstract][Full Text] [Related]
11. [Protective effect of trehalose dimycolate in infestation of mice by Trypanosoma musculi].
Vincendeau P; Daulouède S; Ripert C
C R Acad Sci III; 1986; 302(14):529-32. PubMed ID: 3085878
[TBL] [Abstract][Full Text] [Related]
12. Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production.
Iwasaki T; Nozima T
J Immunol; 1977 Jan; 118(1):256-63. PubMed ID: 401512
[TBL] [Abstract][Full Text] [Related]
13. [Protection of mice by trehalose dimycolate against lethal infection by Trypanosoma cruzi].
Leon LL; Queiroz-Cruz M; Galvao-Castro B; Soares GH; Lima AO; Lederer E
C R Seances Acad Sci III; 1983; 297(6):335-7. PubMed ID: 6420005
[TBL] [Abstract][Full Text] [Related]
14. Antiviral action of trehalose dimycolate against EMC virus: role of macrophages and interferon alpha/beta.
Guillemard E; Geniteau-Legendre M; Mabboux B; Poilane I; Kergot R; Lemaire G; Petit JF; Labarre C; Quero AM
Antiviral Res; 1993 Oct; 22(2-3):201-13. PubMed ID: 7506511
[TBL] [Abstract][Full Text] [Related]
15. Tumor regression after intralesional injection of emulsified trehalose-6,6'-dimycolate (cord factor): efficacy increases with oil concentration.
Yarkoni E; Meltzer MS; Rapp HJ
Int J Cancer; 1977 Jun; 19(6):818-21. PubMed ID: 326683
[TBL] [Abstract][Full Text] [Related]
16. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "sho-seiryu-to"--stimulation of mucosal immune system and effect on allergic pulmonary inflammation model mice.
Nagai T; Yamada H
Immunopharmacol Immunotoxicol; 1998 May; 20(2):267-81. PubMed ID: 9653672
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary TCR γδ T cells induce the early inflammation of granuloma formation by a glycolipid trehalose 6,6'-dimycolate (TDM) isolated from Mycobacterium tuberculosis.
Saitoh T; Yano I; Kumazawa Y; Takimoto H
Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):815-23. PubMed ID: 22963130
[TBL] [Abstract][Full Text] [Related]
18. Modulation of natural killer cytotoxicity by muramyl dipeptide and trehalose dimycolate incorporated in squalane droplets.
Masihi KN; Lange W; Rohde-Schulz B
Cancer Immunol Immunother; 1987; 24(1):19-24. PubMed ID: 3815418
[TBL] [Abstract][Full Text] [Related]
19. Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection.
Masihi KN; Brehmer W; Lange W; Ribi E
Int J Immunopharmacol; 1983; 5(5):403-10. PubMed ID: 6654538
[TBL] [Abstract][Full Text] [Related]
20. [The pathogenesis of trehalose dimycolate-induced hemorrhagic pneumonia induced in mice as animal model of human alveolar hemorrhagic syndrome].
Sakamoto Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Feb; 27(2):206-13. PubMed ID: 2787442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
